Sign In
Buy EBS
$7.93
-0.280 (-3.41%)
At Close: Jun 03, 2026
GAITHERSBURG, Md. & BURLINGAME, Calif.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) (Emergent) and Humanigen, Inc. (NASDAQ:HGEN) (Humanigen) today announced that they have entered into a co
Emergent BioSolutions: Long-Term Thesis Remains Intact
03:43pm, Thursday, 14'th Jan 2021
Emergent BioSolutions remains well insulated from peers, with key COVID-19 vaccine drivers and exposure to adjacent specialty markets in public crises prevention. Additional drivers in contract manufa
Emergent Biosolutions CEO discusses role in helping to bring coronavirus vaccines to market
07:41pm, Monday, 11'th Jan 2021
Emergent Biosolutions CEO Bob Kramer joined Jim Cramer on "Mad Money" to give an update on the coronavirus vaccine manufacturing front.
Emergent Biosolutions CEO gives assessment on Operation Warp Speed
07:40pm, Monday, 11'th Jan 2021
Emergent Biosolutions CEO Bob Kramer gave his thoughts on the results of Operation Warp Speed to help bring a coronavirus vaccine to market.
Emergent (EBS) Posts Preliminary '20 Results, Gives 2021 View
10:32am, Monday, 11'th Jan 2021
Emergent (EBS) tightens revenue view for 2020 and expects a consistent rise in sales of contract development and manufacturing services provided to other companies.
Emergent BioSolutions Announces 2021 Financial Guidance, Provides Preliminary 2020 Results
02:00pm, Sunday, 10'th Jan 2021
GAITHERSBURG, Md., Jan. 10, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE:EBS) today announced its financial forecast for 2021 and selected preliminary unaudited financial results for 2020
3 Reasons Why Growth Investors Shouldn't Overlook Emergent Biosolutions (EBS)
01:32pm, Thursday, 07'th Jan 2021
Emergent Biosolutions (EBS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Emergent Biosolutions (EBS) Outpaces Stock Market Gains: What You Should Know
06:48pm, Wednesday, 06'th Jan 2021
Emergent Biosolutions (EBS) closed the most recent trading day at $97.97, moving +1.01% from the previous trading session.
Is Emergent Biosolutions (EBS) Outperforming Other Medical Stocks This Year?
12:02pm, Wednesday, 06'th Jan 2021
Is (EBS) Outperforming Other Medical Stocks This Year?
Is Emergent BioSolutions Stock a Buy?
07:03am, Tuesday, 05'th Jan 2021
This biotech is about to tackle an enormous market opportunity as coronavirus vaccines receive regulatory clearance.
Emergent BioSolutions to Participate in Investor Conferences
06:30am, Monday, 04'th Jan 2021
GAITHERSBURG, Md., Jan. 04, 2021 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company's executive management team will participate in the following in
GAITHERSBURG, Md. and NEW YORK, Dec. 29, 2020 (GLOBE NEWSWIRE) -- Emergent BioSolutions (NYSE: EBS) and Mount Sinai Health System today announced initiation of the clinical program to evaluate Emergen
3 Bargain Stocks You Can Buy Today
06:14am, Friday, 27'th Nov 2020
Investors have been selling these stocks, but patient investors should take advantage of the opportunity.
2 Pick-and-Shovel COVID Vaccine Stocks to Watch
07:03am, Monday, 23'rd Nov 2020
Could these stocks be winners regardless of which coronavirus vaccine comes out on top?
Why Emergent BioSolutions Slipped on Friday
06:50pm, Friday, 06'th Nov 2020
While profitability came in above estimates, the company missed big on the top line.
